Merchavia Holdings and Investments Ltd (MRHL) fair value: what the stock is really worth
As of Oct 8, 2026: fair value of Merchavia Holdings and Investments Ltd ILS 0.49, price ILS 1.22, upside -59.8%, quality 35 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range 0.5870 ILA – 4.17 ILA · fair‑value band 0.3700 ILA – 0.7300 ILA · the 1.22 ILA price screens above the 0.4900 ILA fair value. Dashed = 300-day average. As of Oct 3, 2026.
Follow Merchavia Holdings and Investments in your weekly email
Every Wednesday you see whether Merchavia Holdings and Investments is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Merchavia Holdings and Investments Ltd is a principal investment firm. The firm prefers to invest in companies doing business in technology, med-tech, medicine, medical products, medical solutions and medical distribution related sectors. It prefers to invest in companies related to Cleveland Clinic.
Show more
Merchavia Holdings and Investments Ltd is a principal investment firm. The firm prefers to invest in companies doing business in technology, med-tech, medicine, medical products, medical solutions and medical distribution related sectors. It prefers to invest in companies related to Cleveland Clinic. Merchavia Holdings and Investments Ltd was founded in 1972 and is based in Bnei Brak, Israel with additional office in Bnei Brak, Israel.
Stock analysis
Merchavia Holdings and Investments Ltd (MRHL) currently trades at 1.22 ILA, while our model-based Fair Value estimate is 0.4900 ILA, 59.8% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: 0.3700 ILA (bear) to 0.7300 ILA (bull), the price of 1.22 ILA sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Merchavia Holdings and Investments Ltd reported revenue of 415K ILA in FY2025 versus 10.6M ILA in FY2021, a compound −55.5%/yr. Reported net income was −10.2M ILA in FY2025.
Key figures
Market cap 25.6M ILA · P/E ratio 17.4 · EPS (TTM) 0.0700 ILA · Return on equity −33.2% · Return on assets (EBIT) −16.6% · Operating margin −1,019% · Revenue growth (YoY) +114% · EPS growth (YoY) +11.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 59% below its 52-week high and 46% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −60%, MRHL screens richer than that median.
Fair Value models
Bear 0.3700 ILAFair Value 0.4900 ILABull 0.7300 ILA
Price 1.22 ILA · Upside -59.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0543 ILS per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−53.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−43.8%
Start year 2020 (pandemic). Over 10 years: −17.3% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−8.7%
’13
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−39.9% (2020) → −2,444.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Merchavia Holdings and Investments Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 242 stocks
Beats the industry median on 4/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score35 · Bottom 25%
Fair Value upside−59.8% · Bottom 25%
Profitability
Return on assets−4.9% · Bottom 25%
Growth and dividend
Revenue growth113.8% · Top 25%
Balance sheet
Debt / equity0.12× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (TTM)17.4× · Cheaper than median
P/B0.54× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 32
FUTURE (revenue growth)100· sector 28
PAST (return on equity)0· sector 33
HEALTH (low debt)94· sector 90
DIVIDEND (yield)0· sector 38
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Merchavia Holdings and Investments Ltd Fair Value". https://www.fairvalue-calculator.com/stock/MRHL
Frequently asked questions
Is Merchavia Holdings and Investments Ltd (MRHL) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 0.4900 ILA versus a price of 1.22 ILA, about −60% upside (overvalued).
What is the fair value of MRHL?
Our model-based fair value for Merchavia Holdings and Investments Ltd is 0.4900 ILA (as of Oct 3, 2026), built from audited fundamentals. The current price: 1.22 ILA.
What is the quality score of MRHL?
Merchavia Holdings and Investments Ltd has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Merchavia Holdings and Investments Ltd (MRHL)?
Our model-based price target is the fair value of 0.4900 ILA (as of Oct 3, 2026) from 1 valuation models. Cautious scenario 0.3700 ILA, optimistic scenario 0.7300 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Merchavia Holdings and Investments Ltd stock forecast for 2026?
Our models put fair value at 0.4900 ILA, about −60% upside versus a price of 1.22 ILA (overvalued). Cautious scenario 0.3700 ILA, optimistic scenario 0.7300 ILA. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Merchavia Holdings and Investments Ltd (MRHL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Merchavia Holdings and Investments Ltd it is 0.4900 ILA per share (as of Oct 3, 2026), against a price of 1.22 ILA. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Merchavia Holdings and Investments Ltd stock overvalued or undervalued in 2026?
As of Oct 3, 2026, MRHL trades above its calculated fair value: price 1.22 ILA, fair value 0.4900 ILA, a gap of about −60% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MRHL?
No. The price is what the market pays today (1.22 ILA); the fair value is what the company's own numbers justify (0.4900 ILA). For Merchavia Holdings and Investments Ltd the two are 0.7300 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Merchavia Holdings and Investments Ltd worth?
The market values Merchavia Holdings and Investments Ltd at about 25.6M ILA (market capitalisation, as of Oct 3, 2026). Per share that is 1.22 ILA; our models calculate a fair value of 0.4900 ILA per share.
What do the bullish and bearish scenarios say about MRHL?
Our models span a range for Merchavia Holdings and Investments Ltd: cautious scenario 0.3700 ILA, base 0.4900 ILA, optimistic 0.7300 ILA per share (as of Oct 3, 2026, price 1.22 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MRHL?
Merchavia Holdings and Investments Ltd trades at a price-to-earnings ratio of 17.4 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.4900 ILA is built from several models across several years. Other multiples: P/B 0.5.
How solid is the balance sheet of Merchavia Holdings and Investments Ltd (MRHL)?
Balance-sheet figures for Merchavia Holdings and Investments Ltd (as of Oct 3, 2026): return on equity −33.2%, debt of 0.12 per unit of equity. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is MRHL from its 52-week high?
Merchavia Holdings and Investments Ltd trades at 1.22 ILA, about 59% below its 52-week high of 2.99 ILA and 46% above the low of 0.8370 ILA (as of Oct 8, 2026). Distance from the high says nothing about value: that is what the fair value of 0.4900 ILA is for.
Which stocks are comparable to Merchavia Holdings and Investments Ltd?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Merchavia Holdings and Investments Ltd stock attractive at the current price?
The data as of Oct 3, 2026: price 1.22 ILA, calculated fair value 0.4900 ILA (−60%), Quality Score 35/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MRHL calculated?
We run Merchavia Holdings and Investments Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.4900 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Merchavia Holdings and Investments Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Merchavia Holdings and Investments Ltd (MRHL)?
The closing price on Oct 8, 2026 was 1.22 ILA. Our model-based fair value is 0.4900 ILA, about −60% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Merchavia Holdings and Investments Ltd right now?
The price sits above even our optimistic bull case (0.7300 ILA). The favourable scenario is already priced in. Weak quality (35/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (0.3700 ILA to 0.7300 ILA) leaves room in how you read the outcome.
Key figures of Merchavia Holdings and Investments Ltd
How large is the market capitalisation of Merchavia Holdings and Investments Ltd (MRHL)?
The market capitalisation of Merchavia Holdings and Investments Ltd is 25.6M ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Merchavia Holdings and Investments Ltd (MRHL)?
Earnings per share at Merchavia Holdings and Investments Ltd are 0.0700 ILA (price ÷ EPS = P/E 17.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Merchavia Holdings and Investments Ltd (MRHL)?
The return on equity (ROE) of Merchavia Holdings and Investments Ltd is −33.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Merchavia Holdings and Investments Ltd (MRHL)?
On an EBIT basis the return on assets of Merchavia Holdings and Investments Ltd is −16.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Merchavia Holdings and Investments Ltd (MRHL)?
The operating margin of Merchavia Holdings and Investments Ltd is −1,019% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Merchavia Holdings and Investments Ltd (MRHL)?
Revenue at Merchavia Holdings and Investments Ltd is growing +114% versus a year earlier (3y avg −53.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Merchavia Holdings and Investments Ltd (MRHL)?
Earnings per share at Merchavia Holdings and Investments Ltd are growing +11.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Merchavia Holdings and Investments Ltd (MRHL) generate?
The free cash flow of Merchavia Holdings and Investments Ltd is −1.5M ILA (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Merchavia Holdings and Investments Ltd (MRHL) carry?
The net debt of Merchavia Holdings and Investments Ltd is 349K ILA (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Merchavia Holdings and Investments Ltd in the live analysis
One click puts Merchavia Holdings and Investments Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
